IP Library Granted Patent US 11,495,360
Granted Patent B2
US 11,495,360 · App. 17/731,779 · Granted Nov 8, 2022

Computer implemented identification of treatments for predicted predispositions with clinician assistance

Inventors: Andrew Alexander Kenedy (Sugar Land, TX); Charles Anthony Eldering (Furlong, PA)
Assignee: 23andMe, Inc.
G16H70/20G06F16/00G06F16/2282G06F16/24575G06F16/24578G06F16/285G06F16/951G06F16/955G06F16/9535G06N3/08G06N5/04G06N7/005G06Q40/08G16B20/00G16B20/20G16B20/40G16H20/30G16H40/63G16H50/30G16H50/70
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,495,360
App. No.
17/731,779
Granted
Nov 8, 2022
Kind
B2
Abstract

A method, software, database and system for attribute partner identification and social network based attribute analysis are presented in which attribute profiles associated with individuals can be compared and potential partners identified. Connections can be formed within social networks based on analysis of genetic and non-genetic data. Degrees of attribute separation (genetic and non-genetic) can be utilized to analyze relationships and to identify individuals who might benefit from being connected.

Claims (41)

1. A computer-implemented method comprising:

obtaining, by a genetics platform, self-reported user data and genetic attributes for a particular user, wherein the genetics platform includes software executing on one or more computing devices, and wherein the self-reported user data includes behaviors or experiences of the particular user;

storing, by the genetics platform, the self-reported user data and the genetic attributes of the particular user in one or more databases;

based on the self-reported user data and the genetic attributes of the particular user, determining, by the genetics platform, a set of modifiable attributes that are exhibited by the particular user; and

providing, by the genetics platform and to a client device, an indication of the set of the modifiable attributes, wherein the modifiable attributes include one or more of interventions, lifestyle modifications, or clinical therapies selected by a clinician.

2. The computer-implemented method of claim 1 , wherein determining the set of modifiable attributes that are exhibited by the particular user is also based on phenotypic attributes of the particular user.

3. The computer-implemented method of claim 1 , further comprising:

receiving, by the genetics platform, clinical user data for the particular user from the clinician or a health care provider; and

storing, by the genetics platform, the clinical user data in the one or more databases, and wherein determining the set of modifiable attributes that are exhibited by the particular user is also based on the clinical user data.

4. The computer-implemented method of claim 3 , wherein the clinical user data relates to one or more of a blood sugar level, a blood pressure, a medical treatment, a medication, an historical treatment, a hospitalization, or a surgery.

5. The computer-implemented method of claim 1 , further comprising:

based on the genetic attributes of the particular user, predicting, by the genetics platform, that the particular user exhibits a particular phenotype.

6. The computer-implemented method of claim 5 , wherein predicting that the particular user exhibits the particular phenotype is also based on one or more of age data, sex-type data, family history, or environmental exposures of the particular user.

7. The computer-implemented method of claim 5 , wherein the modifiable attributes influence expression of the particular phenotype.

8. The computer-implemented method of claim 1 , wherein the genetics platform supports communication between the particular user and the clinician.

9. The computer-implemented method of claim 1 , wherein the modifiable attributes are behavioral attributes.

10. The computer-implemented method of claim 1 , wherein the genetic attributes are non-monogenetic.

11. The computer-implemented method of claim 1 , wherein the genetic attributes are single nucleotide polymorphisms.

12. The computer-implemented method of claim 1 , wherein the genetic attributes are selected from an entire genome.

13. The computer-implemented method of claim 1 , further comprising:

based on the genetic attributes, determining, by the genetics platform, that the modifiable attributes are statistically associated with a predisposition for a particular phenotype.

14. The computer-implemented method of claim 13 , wherein determining that the modifiable attributes are statistically associated with the predisposition for the particular phenotype comprises:

determining statistical associations between combinations of the modifiable attributes and the particular phenotype; and

selecting the combinations of the modifiable attributes having at least a minimum statistical association with the particular phenotype.

15. The computer-implemented method of claim 13 , wherein determining that the modifiable attributes are statistically associated with the particular phenotype comprises training a linear-regression-based or logistic-regression-based model on at least genetic attributes and phenotypic attributes for a population to predict predisposition for the particular phenotype, and wherein determining the set of the modifiable attributes that are exhibited by the particular user comprises applying the linear-regression-based or the logistic-regression-based model to the genetic attributes of the particular user.

16. The computer-implemented method of claim 1 , wherein determining the set of the modifiable attributes that are exhibited by the particular user is also based on timestamped historical physical attributes or timestamped historical behavioral attributes of the particular user.

17. The computer-implemented method of claim 1 , wherein attributes of the self-reported user data are timestamped, and wherein determining the set of the modifiable attributes that are exhibited by the particular user comprises predicting onset or progression of disease based on the attributes as timestamped.

18. The computer-implemented method of claim 1 , wherein determining that the set of modifiable attributes that are exhibited by the particular user comprises calculating a risk associated with the particular user exhibiting a particular phenotype.

19. A non-transitory computer-readable medium storing program instructions that, when executed by a processor, cause a computing system to perform operations comprising:

obtaining self-reported user data and genetic attributes for a particular user, wherein the self-reported user data includes behaviors or experiences of the particular user;

storing the self-reported user data and the genetic attributes of the particular user in one or more databases;

based on the self-reported user data and the genetic attributes of the particular user, determining a set of modifiable attributes that are exhibited by the particular user; and

providing, to a client device, an indication of the set of the modifiable attributes, wherein the modifiable attributes include one or more of interventions, lifestyle modifications, or clinical therapies selected by a clinician.

20. A computing system comprising:

one or more processors;

memory; and

program instructions stored in the memory that, when executed by the one or more processors, cause the computing system to perform operations comprising:

obtaining self-reported user data and genetic attributes for a particular user, wherein the self-reported user data includes behaviors or experiences of the particular user;

storing the self-reported user data and the genetic attributes of the particular user in one or more databases;

based on the self-reported user data and the genetic attributes of the particular user, determining a set of modifiable attributes that are exhibited by the particular user; and

providing, to a client device, an indication of the set of the modifiable attributes, wherein the modifiable attributes include one or more of interventions, lifestyle modifications, or clinical therapies selected by a clinician.

Assignments (5)
CORRECTIVE ASSIGNMENT TO CORRECT THE APP. NO. 63806415 TO 63806145 AND APPL NO. 17721779 TO 17731779 PREVIOUSLY RECORDED ON REEL 73168 FRAME 531. ASSIGNOR(S) HEREBY CONFIRMS THE CHANGE OF NAME. Recorded Jan 6, 2026
From: 23ANDME PGS LLC
To: 23ANDME GENOMICS LLC
Reel/Frame 074434/0334 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 26, 2025
From: 23ANDME, INC.
To: 23ANDME PGS LLC
Reel/Frame 072562/0795 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 28, 2022
From: KENEDY, ANDREW A.; ELDERING, CHARLES A.
To: EXPANSE NETWORKS, INC.
Reel/Frame 059759/0419 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 28, 2022
From: EXPANSE BIOINFORMATICS, INC.
To: 23ANDME, INC.
Reel/Frame 059761/0618 →
CHANGE OF NAME Recorded Apr 28, 2022
From: EXPANSE NETWORKS, INC.
To: EXPANSE BIOINFORMATICS, INC.
Reel/Frame 059845/0449 →
Continuity (8)
Continuation 17590304 · Feb 1, 2022
Continuation 17175995 · Feb 15, 2021
Continuation 17004494 · Aug 27, 2020
Continuation 15927785 · Mar 21, 2018
Continuation 14822023 · Aug 10, 2015
Continuation 12047203 · Mar 12, 2008
Provisional Application 60895236 · Mar 16, 2007
Related Publication 20220254512A1 · Aug 11, 2022
Cited By (1)
US 12,488,901